Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: J Neurovirol. 2020 Jan 27;26(2):226–240. doi: 10.1007/s13365-020-00826-3

Table 1.

Participant demographic, depressive symptom, and clinical characteristics

AHI
(n = 74)*
Uninfected controls
(n = 30)*
P-values
Demographic Information
Agea 28.9 (8.9) 30.2 (5.4) p = .461
Sex (% Male)a 100% 66.7%b p < .0005
Education levela p = .045
 No certificate/primary school certificate 2.7% 0%
 Less than high school certificate/vocational certificate 5.4% 23.3%
 High school certificate or higher vocational or diploma 35.1% 33.3%
 Bachelor degree or higher 56.8% 43.3%
Motion Summary Measure
Average RMS 28.5 (14.3) 27.6 (9.9) p = .754
Depressive Symptom Measure
HADS-Dc 5.2 (4.2) 3.2 (1.9) p = .005
HIV-Related Clinical Variables
Time since infection (days) 19.0 (6.6)
Fiebig stage I, n (%) 7 (9.5%)
Fiebig stage II, n (%) 15 (20.3%)
Fiebig stage III, n (%) 43 (58.1%)
Fiebig stage IV, n (%) 5 (6.8%)
Fiebig stage V, n (%) 4 (5.7%)
CD4 394.8 (209.4)
CD8 680.9 (507.0)
CD4:CD8 ratio 0.8 (0.5)
HIV RNA (log 10 copies) 6.0 (1.1)

Notes. AHI = Acute HIV; RMS = relative root mean squared displacement; HADS-D = Hospital Anxiety and Depression Scale-depression subscale score.

a

Sex and education level were significantly different between groups (chi-square tests). There were no significant group differences in age (independent samples t-test).

b

For control group, 26.7% female (8), 66.7% male (20), and 6.7% transgender (2)

c

Based on data for n = 64 AHI subjects and n = 20 for uninfected control participants*; total HADS-D scores ranged from 0 to 18. There were significant group differences in depressive symptoms (independent samples t-test).